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H I G H L I G H T S
• Physical activity is a modifiable risk factor for cardiovascular disease.
• Individuals with a diagnosis of peripheral artery disease (PAD) tend to be less physically active, regardless of whether activity was self-reported or measured
objectively.
• The findings from the longitudinal studies suggest that more intense physical activity is associated with lower risk of developing PAD.
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A B S T R A C T
Background and aims: Physical activity is a modifiable risk factor for cardiovascular disease and an important
therapy in individuals with intermittent claudication. However, its role in the development of peripheral artery
disease (PAD) is unclear. We have examined the evidence of the association between physical activity and
development of PAD.
Methods: We searched PubMed, EMBASE and CINAHL Plus in August 2018 for original studies of physical ac-
tivity and PAD. Studies reporting prevalence or incidence of PAD by categories of physical activity (an amount of
activity per unit of time) were included. In addition, we analysed unpublished individual-level data from two
register-linked cohort studies, Finnish Public Sector Study (n= 63,924) and Whitehall II (n= 10,200). Due to
heterogeneity in the assessment of physical activity and PAD, we provide a qualitative synthesis of the findings.
Results: Evidence from 18 studies (15 cross-sectional/case-control and 7 prospective studies) of the association
between physical activity and PAD in total of 152,188 participants, including 3971 PAD patients, suggests that
individuals with a diagnosis or clinical findings of PAD were less physically active, regardless of whether activity
was self-reported or measured using accelerometers. The findings from the longitudinal studies point to more
intense physical activity being associated with lower odds of developing PAD; however, the study-specific
findings lacked power to precisely estimate this relationship.
Conclusions: Individuals with PAD were less physically active than those without PAD. The longitudinal findings
suggest that physical activity decreases the risk of PAD, although better powered studies are needed to confirm
this.
1. Introduction
Peripheral artery disease (PAD) affects over 200 million people
worldwide and it is the third most common cause of cardiovascular
morbidity, after stroke and coronary heart disease [1]. With an in-
creasing prevalence in both high- and low-income countries, PAD in-
curs considerable costs to patients and healthcare systems alike, in
terms of decreased quality of life, loss of healthy life-years and medical
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and surgical treatment [2,3]. Despite the increasing burden of PAD, the
evidence on risk factors specific to this manifestation of cardiovascular
disease is scarce, and specific treatment targets are lacking [4].
At present the primary and secondary preventive treatment for PAD
is identical to the prevention of coronary and carotid atherosclerotic
disease, with reducing cholesterol, hypertension, smoking, and obesity
as the main interventional targets [4]. Although different manifesta-
tions of cardiovascular disease share many risk factors, the magnitude
of the risk incurred by specific exposures varies between disease out-
comes. For example, smoking, hypertension and type-2 diabetes have
been consistently shown to be associated with an increased risk of
coronary artery disease as well as PAD [1,5], but there is evidence that
the effects of other risk factors may differ, e.g. with cholesterol being
more strongly implicated in coronary heart disease and chronic in-
flammation in PAD [6]. Whilst addressing the coronary and carotid
therapeutic targets is undoubtedly beneficial to patients at risk of PAD
or living with this disease, more explicit evidence on the risk factors
specific to peripheral artery atherosclerotic disease is needed to inform
clinical practice and the development of guidelines aiming to reduce
the incidence and improve prognosis of PAD at individual- and popu-
lation-levels.
One important modifiable risk factor for cardiovascular disease is
low level of physical activity [7]. Randomised controlled trials have
shown that physical activity interventions, particularly supervised ex-
ercise programmes, are also effective secondary preventive measures in
patients with intermittent claudication, as they improve patient-re-
levant outcomes, such as overall walking distance and speed as well as
pain-free walking distance in this patient group [8,9]. However, the
potential role of self-initiated physical activity in the development of
PAD is unclear. A link between physical activity and the incidence of
PAD would lend weight to the increasing role of physical activity and
exercise as part of primary prevention strategies for atherosclerotic
cardiovascular disease in general and PAD in particular. Here we have
systematically reviewed and summarised the currently available evi-
dence of association between self-initiated physical activity and PAD.
2. Materials and methods
2.1. Systematic searches
We searched PubMed, EMBASE and CINAHL Plus from the inception
of each database up to 31 August 2018 for studies comparing physical
activity levels in individuals with and without PAD. Briefly, we sear-
ched for original studies in humans, indexed with “physical activity” or
“exercise” and “peripheral artery occlusive disease” or “peripheral ar-
tery disease” as keywords or Medical Subject Heading terms. No limits
were set on study design or language of publication. Details of the
search terms used are provided in Online Supplement.
Two reviewers (KH and JIH) independently screened titles and ab-
stracts, reviewed full-text articles, selected relevant ones for inclusion,
and extracted data on participant characteristics, association estimates
and their confidence intervals. Any discrepancies or disagreements in
identifying studies or extracting data were solved by discussion with a
third reviewer (PAC). Relevant version (for case-control, cross-sectional
or cohort studies) of the Newcastle-Ottawa scale was used to assess the
risk of bias in the included studies.
2.2. Inclusion and exclusion criteria
The key inclusion criterion was that the studies reported results on
physical activity, as an amount of activity per unit of time, for in-
dividuals with and without PAD. Where more than one article described
analyses of physical activity and PAD in the same dataset [5,10], the
more recently published or larger study was included in the summary of
evidence [10].
Laboratory-based studies, case-studies, case series and reviews were
excluded. We further excluded studies in which physical activity was
not reported as an amount of activity per unit of time. To facilitate
within- and between-studies comparisons, studies in which all partici-
pants had PAD or all participants were free of PAD during the study-
period were excluded. As the focus of our review was to examine the
associations between self-initiated physical activity and PAD, studies of
physical activity interventions as a secondary preventative measure in
individuals with PAD were excluded. This literature has been ex-
tensively reviewed previously [8,9,11] and the findings are compared
to those of the current review in the Discussion.
2.3. Additional analyses on unpublished prospective individual-participant
data
In addition to the published studies, we investigated the association
between physical activity and incident PAD using unpublished in-
dividual-participant data from two ongoing prospective cohort studies,
Finnish Public Sector study (63,924 public sector employees, aged
17–69 at baseline in 2000 or 2004) and Whitehall II (10,200 British
Civil Service employees, aged 35–55 at baseline in 1985–1989). All
participants gave informed consent to take part and both study proto-
cols conform to the ethical guidelines of the 1975 Declaration of
Helsinki. The Finnish Public Sector Study was approved by the Helsinki
and Uusimaa hospital district ethics committee. The Whitehall II study
protocol was approved by the University College London Medical
School committee on the ethics of human research.
Physical activity (hours per week) was self-reported at baseline in
both studies. The participants’ study records were linked to national
hospitalisation datasets for information on episodes of hospital care,
and the incidence of lower limb PAD during follow-up was ascertained
from the hospitalisation data using International Classification of
Diseases (ICD) versions 8, 9 and 10 codes indicating intermittent
claudication or lower limb ischaemia, or the Office for Populations
Censuses and Surveys (OPCS) version 4 code indicating a lower limb
procedure relating to PAD (Supplementary Tables S1 and S2). We used
Cox proportional hazards regression (with years since baseline as the
time-scale) to examine the associations between physical activity at
baseline and PAD during follow-up. Analyses were adjusted for age
(years), sex, socioeconomic position and smoking (never, ex-, current).
Details of the Finnish Public Sector study and Whitehall II, as well as
their participants, are provided in the Supplementary Section 4 and
Table S5.
2.4. Evidence synthesis
The assessment and definition of physical activity as well as the
ascertainment of PAD varied between studies. For this reason we
decided against pooling the study-specific estimates in meta-analyses
and have provided a qualitative summary of the findings instead.
3. Results
3.1. Systematic search
The results of the systematic searches are detailed in Fig. 1. Briefly,
we screened 4436 abstracts and selected 35 potentially relevant articles
for full-text review. Of these, 18 articles were excluded. The main
reasons for exclusion were irrelevant exposure (other than an amount of
physical activity per unit of time) or irrelevant outcome (e.g. CVD other
than PAD). After all exclusions, and adding one eligible article from the
citing reference search, 18 articles reporting on the association of
physical activity with prevalent or incident PAD were included in the
review [10,12–28].
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3.2. Study characteristics
A large majority of the studies we reviewed (n=15) had a cross-
sectional or case-control design [10,12–14,16–20,22–26,28] (Table 1
and Supplementary Table S3). Longitudinal analyses were conducted in
only five studies [15,16,18,21,27] (Table 2 and Supplementary Table
S4). Two articles contained both cross-sectional and longitudinal find-
ings [16,18].
In most studies, self-initiated physical activity was self-reported by
the participants [10,12–16,18,21,22,25,27,28], whereas objectively
measured physical activity data, using accelerometers, were collected
in seven studies [17,19,20,23–26]. The most common method for
identifying patients with PAD was the measurement of ankle-brachial
index (ABI: the ratio of blood pressure in the brachial artery and the
dorsalis pedis and posterior tibial arteries). PAD was typically defined
as having ABI< 0.9 [10,14–17,22–24,27,28], though a threshold of
either below 0.9 or above 1.4 (abnormal ABI) was also used in two sets
of analyses [20,22]. A combination of having an ABI below the 0.9
threshold and a clinical diagnosis of PAD was used in three studies
[12,13,25] and one study ascertained incident PAD on the basis of at
least one of the following: ABI lower than 0.9 at rest, clinical evidence
of arterial occlusive disease, or an endovascular or open surgical re-
vascularisation or amputation [21]. In one study PAD was defined
based on the Edinburgh Claudication Questionnaire or having under-
gone a PAD-related procedure [18].
Most studies presented results that were adjusted for a number of
cardiovascular disease risk factors and other covariates that could
confound any observed association between physical activity levels and
PAD [10,13,16,18–21,24,25]. However, in one study the findings were
adjusted for age [14] and five studies presented only unadjusted results
[12,16,22,23,28].
3.3. Findings from cross-sectional and case-control studies
In most cross-sectional and case-control studies individuals with
PAD undertook less self-initiated physical activity and exercised less
strenuously than those without PAD [10,13,14,16–20,23–26]. The di-
rection of this association was the same in unadjusted analyses
[16,23,26], those adjusted for age alone [14], analyses with adjustment
for multiple CVD risk factors and potential determinants of physical
activity levels [10,13,17–20,24,25] as well as in the investigations
where all participants had chronic kidney disease, diabetes, coronary
artery disease or heart failure [13,19,20]. By contrast, in two studies
the investigators reported higher prevalence or odds of PAD in mod-
erately active participants compared to sedentary participants [12,22].
In addition, one article reported no association between ABI and
quantiles of physical activity [28].
A large majority of cross-sectional and case-control studies were
based on relatively small numbers of PAD patients (n with PAD<200,
Supplementary Table S3), although two larger studies from Australia
and the United States had 638 and 754 PAD cases, respectively [13,18].
Also, as expected of PAD patients, many study participants had other,
comorbid diseases (e.g. type-2 diabetes), but the detail to which these
were reported varied. In three studies all participants had a chronic
disease: populations with chronic kidney disease [13], diabetes [20] or
coronary artery disease or chronic heart failure [19] were examined.
An important barrier to physical activity in PAD patients is inter-
mittent claudication, but the presence or absence of this symptom was
incompletely reported in the studies we reviewed. In the only study
focusing on truly asymptomatic patients, the investigators reported
Fig. 1. Systematic search flow diagram.
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lower mean ABI values in men who were inactive and higher values in
those who undertook at least 4 h of light activity per week [16]. In the
majority of the studies in which PAD patients' physical activity levels
were lower than those of comparison groups', PAD was defined as an
ABI≤ 0.9, and it is possible that the low ABI group included patients
with other diseases characterised by low ABI [10,14,17,19,20,23–26].
It is therefore possible that the observed co-occurrence of low levels of
physical activity and PAD in these studies represents diseases other than
PAD (e.g. chronic obstructive pulmonary disease, arthritis or angina
pectoris) impairing the patients’ ability to undertake physical activity.
Taken together, the findings from the cross-sectional and case-
control studies suggest that men and women with PAD are less physi-
cally active than those free of this disease. However, in two studies PAD
patients were more active than the comparison group [12,22]. These
contradicting findings may be residual confounding, as the latter ana-
lyses lacked adjustment for potential confounders. Another possibility is
that these observations represent individuals with early PAD (un-
diagnosed before the onset of the study) using physical activity to al-
leviate the symptoms of the disease.
3.4. Findings from longitudinal analyses
The results from all seven longitudinal analyses suggested that the
more physical activity the participants reported at baseline, the lower
their odds of developing PAD during follow-up were [15,16,18,21,27]
(Whitehall II and Finnish Public Sector study, Table 2 and
Supplementary Table S4). However, the 95% confidence intervals for
all bar two of the point estimates were wide and crossed the null-value.
In the Spanish PREDIMED study (number with incident PAD: 87) the
HR for PAD over a median of 4.8 years of follow-up was 0.45 (95% CI:
0.27 to 0.76) in individuals reporting leisure-time physical activity of
≥500 MET minutes/week, compared to those whose physical activity
levels were lower [21]. In the Finnish Public Sector study (n incident
PAD: 106) the HR for PAD over up to 11 years of follow-up was 0.53
(95% CI: 0.32 to 0.87) among those reporting 30 MET-hours of physical
activity per week (Table 2).
One explanation for the lack of clear evidence for an association
between physical activity and incident PAD is that the longitudinal
studies were underpowered to detect an association between levels of
physical activity and PAD. Although many were based on relatively
Table 1
Summary of findings from cross-sectional and case-control studies of physical activity and peripheral artery disease (PAD).
Reference Main findings
Berard [12] OR (95% CI) for PAD:
No physical activity (ref. cat.)
Some physical activity: 2.7 (1.4–5.4)
Chen [13] OR (95% CI) for PAD, per 1 SD change in METs/week (146 METs): 0.87 (0.78–0.97)
Collins [14] OR (95% CI) for PAD:
Reference category: ideal activity level (≥150min/week of moderate and/or vigorous activity)
Poor (no physical activity): 1.35 (1.00–1.82)
Intermediate (1–149min/wk moderate and/or vigorous activity): 0.98 (0.69–1.38)
Engström [16] Mean (SD) ABI:
Inactive: 0.89 (0.21)
Light activity ≥4hrs/week: 1.01 (0.13)
Moderate/heavy activity ≥2–3 h/week or competitive sport several times a week: 1.05 (0.11)
Kulinski [17] OR (95% CI) for PAD, per 1 SD (13min) increase in daily exercise time: 0.71 (0.57–0.89)
Findings based on objectively measured physical activity.
Lakshmanan [18] OR (95% CI) for PAD:
Exercise <3 h/week: ref. cat.
Exercise ≥3 h/week: 0.78 (0.66–0.93)
Loprinzi 2016 [19] OR (95% CI) for PAD, per 60min/day increase in physical activity: 0.81 (0.67–0.99)
Findings based on objectively measured physical activity.
Loprinzi 2014 [20] OR for PAD, per minute of moderate/vigorous physical activity (activity count ≥2020/min): 0.77 (0.62–0.96)
Maggio [22] Participants with PAD were more active than those without PAD.
McGrae McDermott [23] Mean (SD) activity units: ABI < 0.9: 783.8 (426.2); ABI 0.9-1-5: 1109 (640.1); p < 0.001
Findings based on objectively measured physical activity.
Parsons [24] OR for ABI < 0.9 (95% CI):
…per 10,000 vertical counts/day: 0.92 (0.88–0.96)
…per 1000 steps/day: 0.74 (0.65–0.86)
…per 30min LPA/day: 0.85 (0.74–0.97)
…per 10min MVPA/day: 0.79 (0.70–0.90)
Findings based on objectively measured physical activity.
Ruiz Comellas [10] OR (95% CI) for PAD:
Walking, < 0.5 h/day: ref. cat.
Walking, 0.5–1 h/day: 0.78 (0.49–1.25)
Walking, > 1hr/day: 0.55 (0.35–0.84)
Sieminski [25] Mean (SD) kcal/day, measured by Caltrac accelerometer: PAD: 384 (212); No PAD: 563 (363); p < 0.001
Mean (SD) steps/day, measured by pedometer: PAD: 5163 (3273); No PAD: 9123 (5162); p < 0.001
Mean (SD) kcal/day, measured by Minnesota LTPA: PAD: 149 (161); No PAD: 226 (251); p < 0.001
Mean (SD) activity code, measured by JCS PAS: PAD: 1.5 (1.0); No PAD: 2.7 (1.9); p < 0.001
Findings based on objectively measured physical activity.
Siscovick [26] N (%) with PAD, by physical activity category:
Men: Low intensity: 13 (18.3); Medium intensity: 42 (5.5); High intensity, MET>6:7 (3.7); p=0.01
Women: Low intensity: 19 (10.0); Medium intensity: 50 (5.7); High intensity, MET>6: 5 (2.8); p=0.02
Findings based on objectively measured physical activity.
Wilson [28] Mean (SD) ABI:
No LRA: 0.94 (0.21); LRA Quantile 2: 1.02 (0.18); LRA Q3: 1.03 (0.18); LRA Q4: 1.02 (0.18); LRA Q5: 1.02 (0.17); p < 0.001
ABI: ankle-brachial index; OR: odds ratio; CI: confidence interval; HDL: high density lipoprotein cholesterol; GFR: glomerular filtration rate; BMI: body mass index;
CRP: C-reactive protein; HgbA1C: glycated haemoglobin; CVD: cardiovascular disease; LPA: light physical activity; MVPA: moderate/vigorous physical activity;
LTPA: leisure-time physical activity; kcal: kilocalories; MET: metabolic equivalent; SBP: systolic blood pressure; WHR: waist:hip ratio; LRA: lifetime recreational
activity; Q: quantile.
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large overall sample sizes, the number of incident PAD cases ranged
from 48 to 193 (Supplementary Table S4). Another possible reason for
the point-estimates indicating an association but the 95% confidence
intervals failing to support a trend is that although the investigators
made an effort to exclude from the analyses participants who had PAD
at baseline, some individuals may have had a sub-clinical PAD at the
time physical activity was assessed (e.g. normal resting ABI measure-
ments, but some PAD with good collateralisation), and thus reverse
causality (from early symptoms of PAD causing an individual to be less
physically active) could have diluted the observed associations. Simi-
larly to the cross-sectional studies, the longitudinal studies we reviewed
provided limited and heterogeneous information on the patients'
symptom status: PAD was defined based on low ABI alone [15], inter-
mittent claudication or a procedure for PAD [18], low ABI and lack of
symptoms [16], a combination of low ABI and history of revascular-
isation [27] and hospital records of PAD diagnosis or lower limb re-
vascularisation (Finnish Public Sector study and Whitehall II). Only one
of the longitudinal studies explicitly reported that individuals with PAD
at baseline were excluded from the analyses [21]. In our analyses in
Whitehall II, no data were available on the participants’ PAD-status
before the baseline; however, as the first incident PAD event took place
seven years post-baseline, it seems unlikely that a large number of
prevalent PAD cases would have been included in our analyses. In the
Finnish Public Sector study individuals with a hospital record of PAD at
or before baseline were excluded from the analyses.
4. Discussion
4.1. Summary of findings
Physical activity is an important therapeutic target in treating pa-
tients with intermittent claudication (an early manifestation of PAD),
and encouraging results from clinical trials point to the impact of su-
pervised exercise programmes in improving functional capacity in this
group of patients [8,9,11]. The findings of our systematic review pro-
vide some indication that self-initiated physical activity is associated
with a decreased risk of PAD. However, all the evidence presented here
comes from European high-income countries with universal healthcare
systems, and it is possible that the associations between physical ac-
tivity and PAD are different in low-income settings and in contexts of
limited healthcare access.
4.2. Risk of bias and potential sources for heterogeneity
We are not aware of previous data syntheses of the association be-
tween self-initiated physical activity and the incidence of PAD, which
precludes comparison to other reviews. A large majority of the research
in this area is based on case-control or cross-sectional studies, which
can only provide evidence on the co-occurrence of physical activity or
exercise intensity and PAD. Such findings provide limited information
on the role of physical activity in the development of PAD, as the
presence of the disease will likely impact on participants’ propensity to
undertake physical activity, explaining the observations of PAD patients
having lower levels of physical activity than PAD-free individuals.
The risk of bias in the studies we reviewed varied: many studies
were generally well-conducted, using appropriate measures of physical
activity and PAD outcomes, with the investigators reporting estimates
adjusted for a number of potentially confounding CVD risk factors and
determinants of physical activity. However, some study reports con-
tained unadjusted estimates. The main limitation in the evidence-base
is that a large majority of studies included in our review were based on
small numbers of PAD patients and thus lacked statistical power to
accurately estimate the association between physical activity levels and
concurrent or incident PAD.
Due to differences in the definitions of physical activity and ascer-
tainment of PAD, individual study findings were not pooled in meta-
analyses. However, our qualitative summary of the results indicates
that individuals with PAD tend to be less physically active and that
larger studies, with uniform measurement of physical activity and PAD
outcomes, would be needed to ascertain whether physical activity has a
role in the development of this disease. One way to collect objectively
measured data on duration and intensity of physical activity would be
to use accelerometers now widely available as smart phone apps. As
demonstrated by research in Parkinson's disease, mobile phone accel-
erometers enable the collection of uniform data on physical activity in
older people [29]. This approach could be extended to investigating
physical activity in individuals with PAD or those at risk of developing
this disease. Also, PAD affects legs and thus limits the patients' ability to
walk, but it does not tend to affect cycling and many patients are able to
swim. Future studies would do well to distinguish between different
types of physical activity in order to determine whether the degree to
which association of low levels of physical activity with PAD reflects
walking impairment alone.
The overall findings of our systematic review reflect those of
Table 2
Summary of findings from longitudinal studies of physical activity and per-
ipheral artery disease (PAD).
Reference Main findings
Delaney [15] Mean (SD) MET minutes/week:
Vigorous activity:
Progress to low ABI: 626 (2495)
No ABI change: 982 (2855)
Moderate activity:
Progress to low ABI: 4120 (3800)
No ABI change: 4938 (4517)
No/low activity:
Progress to low ABI: 5471 (2717)
No ABI change: 6096 (2931)
OR (95% CI) for PAD, by activity
category:
No/low activity: ref. cat.
Moderate/vigorous: 0.94 (0.86–1.04)
Vigorous: 0.98 (0.86–1.04)
Engström [16] N (%) PAD at age 68, by physical activity
categories at age 55:
Inactive: 10 (10%)
Light activity, ≥4hrs/week: 34 (16.2%)
Moderate/heavy activity, ≥2–3 h/week or
competitive sport several times a week: 4
(7.4%)
Lakshmanan [18] Authors report that no association between
physical activity and PAD was found.
Tapp [27] OR (95% CI) for PAD, by frequency of
active sport:
>2 times/week: ref. cat.
1-2 times/week: 1.35 (0.66–2.76)
< 1 time/week: 1.44 (0.69–3.02
Never: 1.74 (0.90–3.39)
Lopez Laguna [21] HR (95% CI) for PAD, by LTPA
categories:
LTPA <500 MET minutes/week: ref. cat.
LTPA ≥500 MET minutes/week: 0.45
(0.27–0.76)
Previously unpublished: Whitehall
II
HR (95% CI) for PAD:
Sedentary: 1 (ref. cat.)
0 < 2.5hrs moderate or 0 < 1.25hrs
vigorous activity/week: 0.92 (0.53–1.59)
≥2.5hrs moderate or ≥1.25hrs vigorous
activity/week: 0.90 (0.54–1.51)
Previously unpublished: Finnish
Public Sector Study
HR (95% CI) for PAD:
Low (< 14 MET-hours/week): 1 (ref. cat.)
Moderate (14 < 30 MET-hours/week):
0.67 (0.42–1.06
High (30+ MET-hours/week): 0.53
(0.32–0.87)
ABI: ankle-brachial index; OR: odds ratio; CI: confidence interval; SD: standard
deviation; MET: metabolic equivalent; SBP: systolic blood pressure; CHD: cor-
onary heart disease; HRT: hormone replacement therapy.
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randomised controlled trials of exercise interventions among patients
with intermittent claudication. High quality evidence shows that ex-
ercise programmes in general improve pain-free and maximum walking
distance in people with intermittent claudication [9], and that su-
pervised exercise therapies are more effective at this than home-based
exercise interventions or walking advice, showing benefits that trans-
late to an up to 210m’ increase in maximum walking distance after
three months of therapy [8]. However, the trials provide no clear evi-
dence of exercise improving ABI or flow-mediated dilatation, or having
an impact on the risk of amputation or death in patients with inter-
mittent claudication, suggesting that although exercise is important in
treatment of intermittent claudication, is does not necessarily slow
down or stop disease progression [9,11]. Thus, although our review
provides some indication that higher levels of self-initiated physical
activity may be associated with a lower incidence of PAD and good
quality evidence shows that exercise interventions improve functional
capacity and quality of life in those who already have the disease, it
seems that the benefits of physical activity do not directly translate into
an improved vascular function or lower risk of peripheral artery
atherosclerotic disease.
In conclusion, individuals with PAD tend to be less physically active
than those without the disease. The longitudinal findings suggest that
physical activity decreases the risk of PAD, although better powered
studies are needed to confirm this.
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